Omeros Corporation
$17.34
Market Cap
$1.26B
Shares Outstanding
72.4M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Oct 8, 2009
Round Lot
100
Locale
US
Day Open
$17.16
Day High
$17.99
Day Low
$17.14
Volume
2.11M
VWAP
$17.55
Prev Close
$17.17
Transactions
--
Acc. Volume
--
Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program.
Omeros Corporation (OMER) closed the 2026-09-16 session at $17.34, up 0.99% versus the previous close (+0.17). The stock opened at $17.16 and traded between $17.14 and $17.99 during that session. Session trading volume was 2.1M shares. The volume-weighted average price (VWAP) is $17.55.
Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program.
Omeros Corporation has a market capitalization of $1.26 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. OMER is listed on the XNAS exchange. The company employs approximately 175 people. Omeros Corporation is headquartered in SEATTLE, WA. The recorded listing date is 2009-10-08.
On this page you can find market OMER stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.